Literature DB >> 12525507

Horseshoes, hand grenades, and body-surface area-based dosing: aiming for a target.

Merrill J Egorin.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 12525507     DOI: 10.1200/JCO.2003.10.084

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

1.  Dose-finding and pharmacokinetic study to optimize the dosing of irinotecan according to the UGT1A1 genotype of patients with cancer.

Authors:  Federico Innocenti; Richard L Schilsky; Jacqueline Ramírez; Linda Janisch; Samir Undevia; Larry K House; Soma Das; Kehua Wu; Michelle Turcich; Robert Marsh; Theodore Karrison; Michael L Maitland; Ravi Salgia; Mark J Ratain
Journal:  J Clin Oncol       Date:  2014-06-23       Impact factor: 44.544

Review 2.  Dashboard systems: implementing pharmacometrics from bench to bedside.

Authors:  Diane R Mould; Richard N Upton; Jessica Wojciechowski
Journal:  AAPS J       Date:  2014-06-20       Impact factor: 4.009

3.  Rationale for fixed dosing of pertuzumab in cancer patients based on population pharmacokinetic analysis.

Authors:  Chee M Ng; Bert L Lum; Veronica Gimenez; Steve Kelsey; David Allison
Journal:  Pharm Res       Date:  2006-05-26       Impact factor: 4.200

4.  Population analysis of a 24-h paclitaxel infusion in advanced endometrial cancer: a gynaecological oncology group study.

Authors:  Diane R Mould; Gini F Fleming; Kathleen M Darcy; David Spriggs
Journal:  Br J Clin Pharmacol       Date:  2006-07       Impact factor: 4.335

5.  Developing Exposure/Response Models for Anticancer Drug Treatment: Special Considerations.

Authors:  D R Mould; A-C Walz; T Lave; J P Gibbs; B Frame
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2015-01-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.